Our findings are consistent with Duggan et al. who showed that increasing IGF-1 level was significantly associated with an approximate 2-fold greater increased risk of BC-specific mortality in participants with a BMI > 25 kg/m2, but not in lean women (14). Here, IGF1 is linked to breast cancer.